Advertisement

Picture Kentro Design Is Key to Your Success Berlin 650x100px
Document › Details

Celyad S.A.. (3/23/17). "Press Release: Celyad Reports 2016 Financial and Operating Results and Expected Key Milestones for 2017". Mont-Saint-Guibert.

Organisations Organisation Celyad S.A. (Euronext Brussels + Paris: CYAD, Nasdaq: CYAD)
  Group Celyad (Group)
  Organisation 2 Ono Pharmaceutical Co., Ltd. (TSE: 4528)
  Group Ono Pharmaceutical (Group)
Products Product C-Cure® cell therapy
  Product 2 CAR T-cell technology (Chimeric Antigen Receptor T-Cell technology)
Persons Person Homsy, Christian (Celyad 201904– Non-executive Board Director before CEO of Celyad / Cardio3 BioSciences since 2007)
  Person 2 Jeanmart, Patrick (Hyloris Pharmaceuticals 202004– CFO acting through PaJe SRL before Degroof Petercam + Celyad + IBA)
     


   
Record changed: 2023-06-05

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for Celyad (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Top News Healthtech Company Mika 650x300px




» top